In the News

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi

Digital Biomarker company Koneksa announced an extension to its collaboration with Sanofi in central nervous system clinical trials. Sanofi is one of the world’s top biopharmaceutical companies, and Koneksa CEO Chris Benko expressed enthusiasm for the extension: “We’re proud that our long-term partnership has enabled...

How Hims & Hers built a business entirely centered on telehealth

Healthcare IT News recently interviewed Hims & Hers Chief Operating Officer Melissa Baird about how the company has built its brand around telehealth but still has its origins in helping people deal with conditions that are uncomfortable to talk about—sexual health, mental health, contraception, and hair loss,...

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation

Aetion announced that it is expanding its relationship with the U.S. Food and Drug Administration to use real-world evidence to study COVID-19 interventions and advance regulatory science and innovation. The FDA and Aetion will use the Aetion Evidence Platform, validated software that enables efficient, transparent,...

Trinity Health Invests in Xealth to Accelerate Digital Health

Xealth has announced that Trinity Health, one of the nation’s largest Catholic healthcare systems, has invested in the company, bringing Xealth's total Series B funding to $25 million. This support demonstrates continued provider consensus in adopting digital health in a way that best engages both clinicians and...

Lightship Raises $40 Million to Bring Clinical Trials to Every Patient in Need

Lightship, a virtual-first provider of clinical trials, today announced that it has raised $40 million to create access to clinical research for all patients, and improve diversity among patient groups taking part in clinical trials around the world. The funding round was led by Define Ventures and Brook Byers, with...

Transforming the Rare Disease Landscape with Data

AllStripes, formerly known as RDMD, recently completed a $50 million venture round, which it will use to launch 100 new rare disease research programs. Global Genes recently interviewed AllStripes Co-founder and CEO Nancy Yu about the growing efforts around patient data collection, where AllStripes fits into this...

Press Releases